These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Gregorio GV; Portmann B; Karani J; Harrison P; Donaldson PT; Vergani D; Mieli-Vergani G Hepatology; 2001 Mar; 33(3):544-53. PubMed ID: 11230733 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases. Ardesjö B; Hansson CM; Bruder CE; Rorsman F; Betterle C; Dumanski JP; Kämpe O; Ekwall O J Autoimmun; 2008 Jun; 30(4):273-82. PubMed ID: 18242955 [TBL] [Abstract][Full Text] [Related]
11. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Martins EB; Graham AK; Chapman RW; Fleming KA Hepatology; 1996 May; 23(5):988-93. PubMed ID: 8621180 [TBL] [Abstract][Full Text] [Related]
12. [Antibodies to neutrophilic granulocytes (p-ANCA): a further indication for a common origin of ulcerative colitis and primary sclerosing cholangitis?]. Jahn HU; Zeitz M Z Gastroenterol; 1992 Jun; 30(6):441-2. PubMed ID: 1636280 [No Abstract] [Full Text] [Related]
13. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. Senaldi G; Portmann B; Mowat AP; Mieli-Vergani G; Vergani D Arch Dis Child; 1992 Dec; 67(12):1447-53. PubMed ID: 1489223 [TBL] [Abstract][Full Text] [Related]
14. [Interpretation, applications, and limitations of autoantibodies in chronic autoimmune hepatitis]. Díaz Jouanen E Rev Gastroenterol Mex; 1995; 60(4 Suppl 2):S63-4. PubMed ID: 8948785 [No Abstract] [Full Text] [Related]
15. [Incidence and prevalence of autoimmune liver diseases]. Berdal JE; Ebbesen J; Rydning A Tidsskr Nor Laegeforen; 1998 Nov; 118(29):4517-9. PubMed ID: 9889636 [TBL] [Abstract][Full Text] [Related]